<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Braz J Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Braz J Psychiatry</journal-id>
<journal-id journal-id-type="publisher-id">bjp</journal-id>
<journal-title-group>
<journal-title>Brazilian Journal of Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1516-4446</issn>
<issn pub-type="epub">1809-452X</issn>
<publisher>
<publisher-name>Associação Brasileira de Psiquiatria</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27304256</article-id>
<article-id pub-id-type="pmc">7194264</article-id>
<article-id pub-id-type="doi">10.1590/1516-4446-2015-1777</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Update Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Opioid peptides and gastrointestinal symptoms in autism spectrum disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lázaro</surname>
<given-names>Cristiane P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="corresp" rid="cor1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pondé</surname>
<given-names>Milena P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rodrigues</surname>
<given-names>Luiz E.A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<aff id="aff1">
<label>1</label>Escola Bahiana de Medicina e Saúde Pública (BAHIANA), Salvador, BA, Brazil</aff>
<aff id="aff2">
<label>2</label>Laboratório Interdisciplinar de Pesquisa em Autismo (LABIRINTO), Salvador, BA, Brazil</aff>
<aff id="aff3">
<label>3</label>Departamento de Bioquímica, Laboratório de Pesquisas Básicas, BAHIANA, Salvador, BA, Brazil</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Correspondence: Cristiane Pinheiro Lázaro, Laboratório Interdisciplinar de Pesquisa em Autismo (LABIRINTO), Av. Dom João VI, 295,Brotas, CEP 40290-000, Salvador, BA, Brazil. E-mail: <email>lazarocris@hotmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>38</volume>
<issue>3</issue>
<fpage>243</fpage>
<lpage>246</lpage>
<history>
<date date-type="received">
<day>17</day>
<month>7</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>1</month>
<year>2016</year>
</date>
</history>
<permissions>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Autism spectrum disorders (ASDs) are characterized by deficits in the individual’s ability to socialize, communicate, and use the imagination, in addition to stereotyped behaviors. These disorders have a heterogenous phenotype, both in relation to symptoms and regarding severity. Organic problems related to the gastrointestinal tract are often associated with ASD, including dysbiosis, inflammatory bowel disease, exocrine pancreatic insufficiency, celiac disease, indigestion, malabsorption, food intolerance, and food allergies, leading to vitamin deficiencies and malnutrition. In an attempt to explain the pathophysiology involved in autism, a theory founded on opioid excess has been the focus of various investigations, since it partially explains the symptomatology of the disorder. Another hypothesis has been put forward whereby the probable triggers of ASDs would be related to the presence of bacteria in the bowel, oxidative stress, and intestinal permeability. The present update reviews these hypotheses.</p>
</abstract>
<kwd-group>
<kwd>Autistic disorder</kwd>
<kwd>probability theory</kwd>
<kwd>opioids</kwd>
<kwd>intestinal bacteria</kwd>
<kwd>oxidative stress</kwd>
<kwd>bowel permeability</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Autism spectrum disorder (ASD) is characterized by stereotyped behavior and a deficiency in the individual’s ability to socialize, communicate, and use imagination.<xref ref-type="bibr" rid="B01">1</xref> Although the disorder is associated with neural development, its true causes remain to be clarified. Recent evidence supports the hypothesis of a complex and highly heterogenous genetic etiology, and points to a combined effect between the environment and various different genes.<xref ref-type="bibr" rid="B02">2</xref> As a consequence, phenotypes in ASD appear to be manifold.</p>
<p>Many autistic individuals suffer from gastrointestinal problems<xref ref-type="bibr" rid="B03">3</xref> such as abnormalities of the bowel mucosa, dysfunctions associated with selective permeability, and significant differences in composition of the gut microbiota.<xref ref-type="bibr" rid="B04">4</xref> Individuals with ASD also exhibit an imbalance in immune response.<xref ref-type="bibr" rid="B03">3</xref> Since the gastrointestinal tract has direct connections with the immune system, alterations in the gastrointestinal tract may generate alterations in the immune system.</p>
<p>In an attempt to explain the pathophysiology involved in autism, Panksepp et al.<xref ref-type="bibr" rid="B05">5</xref> conducted a pioneering experimental study with rats and reported a decrease in social cohesion with an increase in opioid peptides in the organism. Recent studies investigated the role of opioid peptides and intestinal permeability,<xref ref-type="bibr" rid="B06">6</xref> as well as alterations in the expression of certain genes.<xref ref-type="bibr" rid="B07">7</xref> Heberling et al.<xref ref-type="bibr" rid="B02">2</xref> suggested that certain gut bacteria, oxidative stress and changes in intestinal permeability could be involved in the etiology of ASD.</p>
<p>Factors related to nutrition, such as gluten and casein intolerance, are under investigation, as they are associated with various gastrointestinal symptoms. Thus, interventions have been implemented in which gluten and casein are excluded from the diet and probiotics and multivitamins are included.<xref ref-type="bibr" rid="B04">4</xref> This update article discusses current hypotheses that associate the etiology of autism with alterations in opioid metabolism and with gastrointestinal tract symptoms.</p>
</sec>
<sec>
<title>The opioid excess theory</title>
<p>Panksepp et al.<xref ref-type="bibr" rid="B05">5</xref> found that an excess of casomorphin, an opioid-like peptide fragment of milk casein, induced social isolation and apathy in animals. Panksepp<xref ref-type="bibr" rid="B08">8</xref> then proposed the opioid excess theory to explain the pathogenesis of ASD and advocated that opioid peptides released from gluten and casein could pass through the mucosa and cross the blood-brain barrier, reaching the central nervous system (CNS) and affecting brain function.</p>
<p>Food-derived bioactive peptides are protein fragments originating from enzymatic hydrolysis and proteolysis induced by microorganisms.<xref ref-type="bibr" rid="B09">9</xref> They consist of oligopeptides (three to 20 amino acids) with distinct functions and conformations.<xref ref-type="bibr" rid="B10">10</xref> Some bioactive peptides act directly on the gastrointestinal lumen, while others act on peripheral organs following absorption in the bowel, playing a role in reducing arterial blood pressure, modulating immune cells, and regulating nervous functions.<xref ref-type="bibr" rid="B11">11</xref> Factors involved in the absorption of these peptides include the inhibition of peptidases<xref ref-type="bibr" rid="B12">12</xref> and the permeability of the intestinal barrier.<xref ref-type="bibr" rid="B13">13</xref> Nevertheless, the opioid excess theory has been criticized due to the fact that no abnormal concentrations of opioid peptides had ever been detected in the plasma or in the CNS of individuals with ASD.<xref ref-type="bibr" rid="B14">14</xref>
</p>
<p>Randomized controlled studies have been conducted to evaluate the efficacy of excluding gluten and casein from the diet of individuals with ASD.<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref> Some results suggested positive effects on behavior and development; however, other studies failed to find any improvement in the intervention group.<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref> Meta-analyses<xref ref-type="bibr" rid="B05">5</xref>,<xref ref-type="bibr" rid="B19">19</xref> recommended caution with respect to adopting this diet because of limited scientific evidence on its use. Furthermore, the dietary restrictions imposed may lead to more social rejection and stigmatization, as well as to deficits in these individuals’ socialization and integration.</p>
</sec>
<sec>
<title>Hypothesis on the association among gut bacteria, oxidative stress, and intestinal permeability</title>
<p>The microbiota of the human gastrointestinal tract plays a central role both in health and in the generation of disease.<xref ref-type="bibr" rid="B03">3</xref> Anaerobic bacteria account for the production of acetic and propionic acid, in addition to short-chain fatty acids, particularly butyric acid, which supplies energy to the intestinal epithelial cells and consequently strengthens the immune system. The principal bacteria producing short-chain fatty acids are <italic>Bacteroides</italic>, <italic>Lactobacillus</italic>, and <italic>Bifidobacterium</italic>, which induce the production of anti-inflammatory cytokines, unlike <italic>Clostridium</italic>, which stimulates the proinflammatory cytokines. Bacteria of the <italic>Clostridium</italic> genus, such as <italic>C. difficile</italic> and <italic>C. perfringens</italic>, are major producers of toxins.<xref ref-type="bibr" rid="B20">20</xref>
</p>
<p>In the intestinal microbiota of individuals with ASD, the amount of bifidobacteria is reduced and there is abnormal growth of <italic>Clostridium</italic> species.<xref ref-type="bibr" rid="B03">3</xref> Finegold et al.<xref ref-type="bibr" rid="B20">20</xref> identified <italic>Desulfovibrio</italic> as the prevalent organism in the intestinal flora of these individuals and found that it modifies the bacterial ecosystem, reducing the presence of important species such as <italic>Bifidobacterium longum</italic> and <italic>B. pseudolongum</italic>, which produce hydrogen sulfate, a gas that is toxic to humans.<xref ref-type="bibr" rid="B03">3</xref>
</p>
</sec>
<sec>
<title>Sulfur metabolism</title>
<p>The oxidation of thiol (sulfhydryl) groups may play a central role in the development of ASD.<xref ref-type="bibr" rid="B03">3</xref> Meta-analyses suggest that there are deficiencies in the transmethylation/transsulfuration metabolism<xref ref-type="bibr" rid="B21">21</xref> associated with the sulfur amino acids methionine and cysteine.</p>
<p>The essential amino acid methionine must be available in the diet to enable cysteine synthesis to occur. Deficiencies in metabolic pathways will compromise the excretion of heavy metals, because cysteine is a limiting factor in the production of reduced glutathione, a natural antioxidant in the body.<xref ref-type="bibr" rid="B22">22</xref> In fact, various metabolic precursors involved in the synthesis of reduced glutathione are decreased in the plasma of individuals with ASD, suggesting that synthesis of this antioxidant may be compromised.<xref ref-type="bibr" rid="B03">3</xref>,<xref ref-type="bibr" rid="B22">22</xref> As a consequence of this metabolic inhibition, autistic individuals may be more sensitive to the toxic effects of heavy metals. Evidence of this was found in urine and blood samples from people with ASD. Compared to those of controls, blood samples from the individuals with ASD showed greater amounts of lead in the red blood cells, while their urine samples showed higher tin, tungsten, and lead levels.<xref ref-type="bibr" rid="B23">23</xref>
</p>
<p>Transmethylation is also involved in the regeneration and conversion of methionine into <italic>S</italic>-adenosylmethionine, which is the most important enzymatic co-factor in the transfer of methyl groups for the biosynthesis of DNA, RNA, proteins, phospholipids, creatinine, and neurotransmitters.<xref ref-type="bibr" rid="B22">22</xref>
</p>
</sec>
<sec>
<title>Intestinal permeability</title>
<p>The proper function of the intestinal mucosal barrier guarantees that the bowel counteracts the entry of microorganisms and molecules, thus preserving its ability to absorb nutrients.<xref ref-type="bibr" rid="B12">12</xref> The secretion of mucins, immunoglobulin A, and antimicrobial peptides strengthens the mucosal barrier in the outer mucus layer, while internally, the immune cells provide this protection.<xref ref-type="bibr" rid="B12">12</xref> The mucosal barrier has physical, biochemical, and immune characteristics that allow it to secure the flow of substances through the paracellular pathway, which is associated with transportation through the intercellular space.<xref ref-type="bibr" rid="B24">24</xref>
</p>
<p>Intestinal permeability to small water-soluble molecules is determined by the tight junctions, which open and close constantly in response to stimuli such as diet, humoral or neuronal signaling, and through inflammatory mediators.<xref ref-type="bibr" rid="B25">25</xref> Although the tight junctions are represented by a complex of more than 50 proteins, there is evidence that the family of claudins (transmembrane proteins) and zonulin<xref ref-type="bibr" rid="B26">26</xref> are involved in the regulation of selective permeability, including size, electric resistance, and preference for ionic charge.<xref ref-type="bibr" rid="B27">27</xref> The delicate nature of this balance is interrupted in pathologic states. It has been reported that zonulin expression increases in autoimmune conditions and is associated with dysfunction of tight junctions. Physiologically, however, exposure of the bowel to bacteria and to gluten triggers zonulin release.<xref ref-type="bibr" rid="B26">26</xref> Some studies suggest that the function of the epithelial barrier is damaged in ASD,<xref ref-type="bibr" rid="B13">13</xref> while others have reported that individuals with ASD are prone to gluten allergy<xref ref-type="bibr" rid="B17">17</xref>; therefore, it would be reasonable to presume that zonulin could be involved in this process.<xref ref-type="bibr" rid="B26">26</xref>
</p>
<p>Heberling et al.<xref ref-type="bibr" rid="B03">3</xref> suggested that the pathogenesis of ASD was associated with the relationship between three factors: oxidative stress with a subsequent metabolic sulfur deficiency, an abnormal growth of gut bacteria, and an increase in intestinal permeability. The metabolic sulfur deficiencies associated with an imbalance in the composition of gut bacteria, principally with a proliferation of <italic>Clostridium</italic> and/or <italic>Desulfovibrio</italic>, together with a reduction in bifidobacteria,<xref ref-type="bibr" rid="B03">3</xref> would explain the association between the first two factors. In addition, the metabolic sulfur deficiency would be self-perpetuating, with decreased total and reduced glutathione levels resulting from the decline in bifidobacteria.<xref ref-type="bibr" rid="B03">3</xref> A dysfunctional intestinal mucosa would, in turn, facilitate the absorption of toxins, bacterial products, lymphocytes, proinflammatory cytokines, and neurotransmitters, which would reach the bloodstream, cross the blood-brain barrier, and cause neuroinflammation.<xref ref-type="bibr" rid="B03">3</xref>
</p>
<p>Although the interactions of the brain, bowel, and microbiome are multifactorial and not yet completely clarified, the vagal system functions as a communication channel between the microbiota and the brain.<xref ref-type="bibr" rid="B27">27</xref> In view of the aforementioned scientific evidence, it is suggested that the microbiome may play an important role in the CNS, both in promoting health and in the genesis and maintenance of pathologic states. There are direct and indirect interactions between the gut-brain axis and microbiome, which may be associated with a new concept of integrative physiology in which associations occur between the neural, immune, and endocrine systems, as well as with nutrients and immune markers of the CNS and gastrointestinal tract.<xref ref-type="bibr" rid="B28">28</xref>
</p>
<p>The mechanisms used by pathogens to influence host behavior have been known for decades; however, evidence is growing for direct, noninvasive interactions with the neurophysiological system. The ability of microorganisms to produce and recognize neurochemical compounds structurally similar to those produced by the host’s nervous system explains how they are able to affect behavior through a non-infectious and, possibly, non-immune-mediated pathway.<xref ref-type="bibr" rid="B29">29</xref> Looking at the microbiome from the standpoint of microbial endocrinology, specific pathways are involved in which microorganisms affect behavior, permitting a new approach for the treatment of mental illnesses by modulating the microbiome-gut-brain axis.<xref ref-type="bibr" rid="B30">30</xref> Studies conducted to investigate these effects have shown that cytokines and inflammatory mediators have known neuronal targets, both in the CNS and in the enteric nervous system (Meissner’s plexus and Auerbach’s plexus).<xref ref-type="bibr" rid="B30">30</xref> The fact that bacteria produce neuroendocrine hormones also suggests that the interaction of the microbiome may go well beyond the bacterial neuroendocrine interactions that occur in infectious diseases.</p>
</sec>
<sec sec-type="conclusions">
<title>Conclusion</title>
<p>Current literature does not support the opioid excess theory, since abnormal opioid peptide levels have never been found in the CNS of individuals with ASD. Nevertheless, oxidative stress in individuals with ASD may be a consequence of metabolic sulfur deficiency, abnormal gut bacteria growth, and increased intestinal permeability, thus suggesting a possible correlation between gastrointestinal abnormalities and symptoms of ASD. These data suggest that it may be possible to improve autism-related symptoms by modulating the microbiome-gut-brain axis in individuals with a specific phenotype. Although the evidence to support opioid-free diets (gluten-free, casein-free) is limited and weak, dietary restrictions should only be introduced after gastrointestinal symptoms have appeared or intolerance or allergy to these foods has been diagnosed.</p>
</sec>
<sec sec-type="COI-statement">
<title>Disclosure</title>
<p>The authors report no conflicts of interest.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B01">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brentani</surname><given-names>H</given-names></name><name><surname>Paula</surname><given-names>CS</given-names></name><name><surname>Bordini</surname><given-names>D</given-names></name><name><surname>Rolim</surname><given-names>D</given-names></name><name><surname>Sato</surname><given-names>F</given-names></name><name><surname>Portolese</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Autism spectrum disorders: an overview on diagnosis and treatment</article-title>
<source/>Rev Bras Psiquiatr
<year>2013</year>
<volume>35</volume>
<fpage>S62</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="pmid">24142129</pub-id></element-citation>
</ref>
<ref id="B02">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Codina-Solè</surname><given-names>M</given-names></name><name><surname>Rodríguez-Santiago</surname><given-names>B</given-names></name><name><surname>Homs</surname><given-names>A</given-names></name><name><surname>Santoyo</surname><given-names>J</given-names></name><name><surname>Rigau</surname><given-names>M</given-names></name><name><surname>Aznar-Laín</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Integrated analysis of whole-exome sequencing and transcriptome profiling in males with autism spectrum disorders</article-title>
<source/>Mol Autism
<year>2015</year>
<volume>6</volume>
<fpage>21</fpage>
<pub-id pub-id-type="pmid">25969726</pub-id></element-citation>
</ref>
<ref id="B03">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heberling</surname><given-names>CA</given-names></name><name><surname>Dhurjati</surname><given-names>PS</given-names></name><name><surname>Sasser</surname><given-names>M</given-names></name></person-group>
<article-title>Hypothesis for a systems connectivity model of Autism Spectrum Disorder pathogenesis: links to gut bacteria, oxidative stress, and intestinal permeability</article-title>
<source/>Med Hypotheses
<year>2013</year>
<volume>80</volume>
<fpage>264</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="pmid">23273906</pub-id></element-citation>
</ref>
<ref id="B04">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Czaja-Bulsa</surname><given-names>G</given-names></name></person-group>
<article-title>Non coeliac gluten sensitivity - A new disease with gluten intolerance</article-title>
<source/>Clin Nutr
<year>2015</year>
<volume>34</volume>
<fpage>189</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="pmid">25245857</pub-id></element-citation>
</ref>
<ref id="B05">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Panksepp</surname><given-names>J</given-names></name><name><surname>Najam</surname><given-names>N</given-names></name><name><surname>Soares</surname><given-names>F</given-names></name></person-group>
<article-title>Morphine reduces social cohesion in rats</article-title>
<source/>Pharmacol Biochem Behav
<year>1979</year>
<volume>11</volume>
<fpage>131</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="pmid">504292</pub-id></element-citation>
</ref>
<ref id="B06">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Souza</surname><given-names>NC</given-names></name><name><surname>Mendonca</surname><given-names>JN</given-names></name><name><surname>Portari</surname><given-names>GV</given-names></name><name><surname>Jordao</surname><given-names>AA</given-names><suffix>Junior</suffix></name><name><surname>Marchini</surname><given-names>JS</given-names></name><name><surname>Chiarello</surname><given-names>PG</given-names></name></person-group>
<article-title>Intestinal permeability and nutritional status in developmental disorders</article-title>
<source/>Altern Ther Health Med
<year>2012</year>
<volume>18</volume>
<fpage>19</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">22516881</pub-id></element-citation>
</ref>
<ref id="B07">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cieślińska</surname><given-names>A</given-names></name><name><surname>Sienkiewicz-Szłapka</surname><given-names>E</given-names></name><name><surname>Wasilewska</surname><given-names>J</given-names></name><name><surname>Fiedorowicz</surname><given-names>E</given-names></name><name><surname>Chwała</surname><given-names>B</given-names></name><name><surname>Moszyńska-Dumara</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Influence of candidate polymorphisms on the dipeptidyl peptidase IV and μ-opioid receptor genes expression in aspect of the β-casomorphin-7 modulation functions in autism</article-title>
<source/>Peptides
<year>2015</year>
<volume>65</volume>
<fpage>6</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="pmid">25625371</pub-id></element-citation>
</ref>
<ref id="B08">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Panksepp</surname><given-names>J</given-names></name></person-group>
<article-title>A neurochemical theory of autism</article-title>
<source/>Trends Neurosci
<year>1979</year>
<volume>2</volume>
<fpage>174</fpage>
<lpage>7</lpage>
</element-citation>
</ref>
<ref id="B09">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muro Urista</surname><given-names>C</given-names></name><name><surname>Alvarez Fernandez</surname><given-names>R</given-names></name><name><surname>Riera Rodriguez</surname><given-names>R</given-names></name><name><surname>Arana Cuenca</surname><given-names>A</given-names></name><name><surname>Tellez Jurado</surname><given-names>A</given-names></name></person-group>
<article-title>Review: Production and functionality of active peptides from milk</article-title>
<source/>Food Sci Technol Int
<year>2011</year>
<volume>17</volume>
<fpage>293</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="pmid">21917640</pub-id></element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wada</surname><given-names>Y</given-names></name><name><surname>Lonnerdal</surname><given-names>B</given-names></name></person-group>
<article-title>Bioactive peptides derived from human milk proteins--mechanisms of action</article-title>
<source/>J Nutr Biochem
<year>2014</year>
<volume>25</volume>
<fpage>503</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="pmid">24411973</pub-id></element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chakrabarti</surname><given-names>S</given-names></name><name><surname>Jahandideh</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name></person-group>
<article-title>Food-derived bioactive peptides on inflammation and oxidative stress</article-title>
<source/>Biomed Res Int
<year>2014</year>
<volume>2014</volume>
<fpage>608979</fpage>
<pub-id pub-id-type="pmid">24527452</pub-id></element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sanchez de Medina</surname><given-names>F</given-names></name><name><surname>Romero-Calvo</surname><given-names>I</given-names></name><name><surname>Mascaraque</surname><given-names>C</given-names></name><name><surname>Martinez-Augustin</surname><given-names>O</given-names></name></person-group>
<article-title>Intestinal inflammation and mucosal barrier function</article-title>
<source/>Inflamm Bowel Dis
<year>2014</year>
<volume>20</volume>
<fpage>2394</fpage>
<lpage>404</lpage>
<pub-id pub-id-type="pmid">25222662</pub-id></element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Magistris</surname><given-names>L</given-names></name><name><surname>Familiari</surname><given-names>V</given-names></name><name><surname>Pascotto</surname><given-names>A</given-names></name><name><surname>Sapone</surname><given-names>A</given-names></name><name><surname>Frolli</surname><given-names>A</given-names></name><name><surname>Iardino</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives</article-title>
<source/>J Pediatr Gastroenterol Nutr
<year>2010</year>
<volume>51</volume>
<fpage>418</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">20683204</pub-id></element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cass</surname><given-names>H</given-names></name><name><surname>Gringras</surname><given-names>P</given-names></name><name><surname>March</surname><given-names>J</given-names></name><name><surname>McKendrick</surname><given-names>I</given-names></name><name><surname>O'Hare</surname><given-names>AE</given-names></name><name><surname>Owen</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Absence of urinary opioid peptides in children with autism</article-title>
<source/>Arch Dis Child
<year>2008</year>
<volume>93</volume>
<fpage>745</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="pmid">18337276</pub-id></element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Whiteley</surname><given-names>P</given-names></name><name><surname>Haracopos</surname><given-names>D</given-names></name><name><surname>Knivsberg</surname><given-names>AM</given-names></name><name><surname>Reichelt</surname><given-names>KL</given-names></name><name><surname>Parlar</surname><given-names>S</given-names></name><name><surname>Jacobsen</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders</article-title>
<source/>Nutr Neurosci
<year>2010</year>
<volume>13</volume>
<fpage>87</fpage>
<lpage>100</lpage>
<pub-id pub-id-type="pmid">20406576</pub-id></element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knivsberg</surname><given-names>AM</given-names></name><name><surname>Reichelt</surname><given-names>KL</given-names></name><name><surname>Hoien</surname><given-names>T</given-names></name><name><surname>Nodland</surname><given-names>M</given-names></name></person-group>
<article-title>A randomised, controlled study of dietary intervention in autistic syndromes</article-title>
<source/>Nutr Neurosci
<year>2002</year>
<volume>5</volume>
<fpage>251</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="pmid">12168688</pub-id></element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnson</surname><given-names>CR</given-names></name><name><surname>Handen</surname><given-names>BL</given-names></name><name><surname>Zimmer</surname><given-names>M</given-names></name><name><surname>Sacco</surname><given-names>K</given-names></name><name><surname>Turner</surname><given-names>K</given-names></name></person-group>
<article-title>Effects of gluten free/casein free diet in young children with autism: a pilot study</article-title>
<source/>J Dev Phys Disabil
<year>2011</year>
<volume>23</volume>
<fpage>213</fpage>
<lpage>25</lpage>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seung</surname><given-names>H</given-names></name><name><surname>Rogalski</surname><given-names>Y</given-names></name><name><surname>Shankar</surname><given-names>M</given-names></name><name><surname>Elder</surname><given-names>JH</given-names></name></person-group>
<article-title>The gluten- and casein-free diet and autism: Communication outcomes from a preliminary double-blind clinical trial</article-title>
<source/>J Med Speech Lang Pathol
<year>2007</year>
<volume>15</volume>
<fpage>337</fpage>
<lpage>45</lpage>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mulloy</surname><given-names>A</given-names></name><name><surname>Lang</surname><given-names>R</given-names></name><name><surname>O’Reilly</surname><given-names>M</given-names></name><name><surname>Sigafoos</surname><given-names>J</given-names></name><name><surname>Lancioni</surname><given-names>G</given-names></name><name><surname>Rispoli</surname><given-names>M</given-names></name></person-group>
<article-title>Addendum to gluten-free and casein-free diets in treatment of autism spectrum disorders: a systematic review</article-title>
<source/>Res Autism Spectr Disord
<year>2011</year>
<volume>5</volume>
<fpage>86</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Finegold</surname><given-names>SM</given-names></name><name><surname>Dowd</surname><given-names>SE</given-names></name><name><surname>Gontcharova</surname><given-names>V</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Henley</surname><given-names>KE</given-names></name><name><surname>Wolcott</surname><given-names>RD</given-names></name><etal></etal></person-group>
<article-title>Pyrosequencing study of fecal microflora of autistic and control children</article-title>
<source/>Anaerobe
<year>2010</year>
<volume>16</volume>
<fpage>444</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="pmid">20603222</pub-id></element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Frustaci</surname><given-names>A</given-names></name><name><surname>Neri</surname><given-names>M</given-names></name><name><surname>Cesario</surname><given-names>A</given-names></name><name><surname>Adams</surname><given-names>JB</given-names></name><name><surname>Domenici</surname><given-names>E</given-names></name><name><surname>Dalla Bernardina</surname><given-names>B</given-names></name><etal></etal></person-group>
<article-title>Oxidative stress-related biomarkers in autism: systematic review and meta-analyses</article-title>
<source/>Free Radic Biol Med
<year>2012</year>
<volume>52</volume>
<fpage>2128</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">22542447</pub-id></element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lázaro</surname><given-names>CP</given-names></name><name><surname>Pondé</surname><given-names>MP</given-names></name><name><surname>Rodrigues</surname><given-names>LE</given-names></name></person-group>
<article-title>Some biochemical implications in autism spectrum disorder</article-title>
<source/>Braz J Med Hum Health
<year>2014</year>
<volume>2</volume>
<fpage>151</fpage>
<lpage>8</lpage>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Adams</surname><given-names>JB</given-names></name><name><surname>Audhya</surname><given-names>T</given-names></name><name><surname>McDonough-Means</surname><given-names>S</given-names></name><name><surname>Rubin</surname><given-names>RA</given-names></name><name><surname>Quig</surname><given-names>D</given-names></name><name><surname>Geis</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Toxicological status of children with autism vs. neurotypical children and the association with autism severity</article-title>
<source/>Biol Trace Elem Res
<year>2013</year>
<volume>151</volume>
<fpage>171</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="pmid">23192845</pub-id></element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krug</surname><given-names>SM</given-names></name><name><surname>Schulzke</surname><given-names>JD</given-names></name><name><surname>Fromm</surname><given-names>M</given-names></name></person-group>
<article-title>Tight junction, selective permeability, and related diseases</article-title>
<source/>Semin Cell Dev Biol
<year>2014</year>
<volume>36</volume>
<fpage>166</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="pmid">25220018</pub-id></element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turner</surname><given-names>JR</given-names></name><name><surname>Buschmann</surname><given-names>MM</given-names></name><name><surname>Romero-Calvo</surname><given-names>I</given-names></name><name><surname>Sailer</surname><given-names>A</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name></person-group>
<article-title>The role of molecular remodeling in differential regulation of tight junction permeability</article-title>
<source/>Semin Cell Dev Biol
<year>2014</year>
<volume>36</volume>
<fpage>204</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="pmid">25263012</pub-id></element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fasano</surname><given-names>A</given-names></name></person-group>
<article-title>Zonulin, regulation of tight junctions, and autoimmune diseases</article-title>
<source/>Ann N Y Acad Sci
<year>2012</year>
<volume>1258</volume>
<fpage>25</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="pmid">22731712</pub-id></element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Angelis</surname><given-names>M</given-names></name><name><surname>Piccolo</surname><given-names>M</given-names></name><name><surname>Vannini</surname><given-names>L</given-names></name><name><surname>Siragusa</surname><given-names>S</given-names></name><name><surname>De Giacomo</surname><given-names>A</given-names></name><name><surname>Serrazzanetti</surname><given-names>DI</given-names></name><etal></etal></person-group>
<article-title>Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified</article-title>
<source/>PLoS One
<year>2013</year>
<volume>8</volume>
<fpage>e76993</fpage>
<pub-id pub-id-type="pmid">24130822</pub-id></element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Grenham</surname><given-names>S</given-names></name><name><surname>Clarke</surname><given-names>G</given-names></name><name><surname>Cryan</surname><given-names>JF</given-names></name><name><surname>Dinan</surname><given-names>TG</given-names></name></person-group>
<article-title>Brain-gut-microbe communication in health and disease</article-title>
<source/>Front Physiol
<year>2011</year>
<volume>2</volume>
<fpage>94</fpage>
<pub-id pub-id-type="pmid">22162969</pub-id></element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lyte</surname><given-names>M</given-names></name></person-group>
<article-title>Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior</article-title>
<source/>PLoS Pathog
<year>2013</year>
<volume>9</volume>
<fpage>e1003726</fpage>
<pub-id pub-id-type="pmid">24244158</pub-id></element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wood</surname><given-names>JD</given-names></name></person-group>
<article-title>Enteric neuroimmunophysiology and pathophysiology</article-title>
<source/>Gastroenterology
<year>2004</year>
<volume>127</volume>
<fpage>635</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="pmid">15300595</pub-id></element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>